126 related articles for article (PubMed ID: 10421068)
1. The accumulation of topotecan in 9L glioma and in brain parenchyma with and without dexamethasone administration.
Straathof CS; van den Bent MJ; Loos WJ; Vecht CJ; Schellens JH
J Neurooncol; 1999 Apr; 42(2):117-22. PubMed ID: 10421068
[TBL] [Abstract][Full Text] [Related]
2. The effect of dexamethasone on the uptake of cisplatin in 9L glioma and the area of brain around tumor.
Straathof CS; van den Bent MJ; Ma J; Schmitz PI; Kros JM; Stoter G; Vecht CJ; Schellens JH
J Neurooncol; 1998 Mar; 37(1):1-8. PubMed ID: 9525832
[TBL] [Abstract][Full Text] [Related]
3. Local distribution into brain tumor and pharmacokinetics of 4-pyridoxate diammine hydroxy platinum, a novel cisplatin derivative, after intracarotid administration in rats with 9L malignant glioma: simultaneous brain microdialysis study.
Tokunaga Y; Nakashima M; Sasaki H; Tomiyama N; Nakashima MN; Ichikawa M; Kaminogo M; Shibata S
Biol Pharm Bull; 2000 Dec; 23(12):1491-6. PubMed ID: 11145184
[TBL] [Abstract][Full Text] [Related]
4. Tissue distribution and antitumor activity of topotecan delivered by intracerebral clysis in a rat glioma model.
Kaiser MG; Parsa AT; Fine RL; Hall JS; Chakrabarti I; Bruce JN
Neurosurgery; 2000 Dec; 47(6):1391-8; discussion 1398-9. PubMed ID: 11126910
[TBL] [Abstract][Full Text] [Related]
5. The effect of dexamethasone on the uptake of p-boronophenylalanine in the rat brain and intracranial 9L gliosarcoma.
Morris GM; Micca PL; Coderre JA
Appl Radiat Isot; 2004 Nov; 61(5):917-21. PubMed ID: 15308168
[TBL] [Abstract][Full Text] [Related]
6. Blood flow and blood-to-tissue transport in 9L gliosarcomas: the role of the brain tumor model in drug delivery research.
Fross RD; Warnke PC; Groothuis DR
J Neurooncol; 1991 Dec; 11(3):185-97. PubMed ID: 1823340
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone effects on [125I]albumin distribution in experimental RG-2 gliomas and adjacent brain.
Nakagawa H; Groothuis DR; Owens ES; Fenstermacher JD; Patlak CS; Blasberg RG
J Cereb Blood Flow Metab; 1987 Dec; 7(6):687-701. PubMed ID: 3693426
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
[TBL] [Abstract][Full Text] [Related]
9. Reproducibility of O-(2-(18)F-fluoroethyl)-L-tyrosine uptake kinetics in brain tumors and influence of corticoid therapy: an experimental study in rat gliomas.
Stegmayr C; Schöneck M; Oliveira D; Willuweit A; Filss C; Galldiks N; Shah NJ; Coenen HH; Langen KJ
Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1115-23. PubMed ID: 26646781
[TBL] [Abstract][Full Text] [Related]
10. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.
Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA
Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448
[TBL] [Abstract][Full Text] [Related]
11. Cereport (RMP-7) increases carboplatin levels in brain tumors after pretreatment with dexamethasone.
Dean RL; Emerich DF; Hasler BP; Bartus RT
Neuro Oncol; 1999 Oct; 1(4):268-74. PubMed ID: 11550318
[TBL] [Abstract][Full Text] [Related]
12. Distribution of estramustine in the BT4C rat glioma model.
Johansson M; Bergenheim AT; D'Argy R; Edman K; Gunnarsson PO; Widmark A; Henriksson R
Cancer Chemother Pharmacol; 1998; 41(4):317-25. PubMed ID: 9488601
[TBL] [Abstract][Full Text] [Related]
13. Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: the factor of the blood-brain barrier.
Neuwelt EA; Barnett PA; Bigner DD; Frenkel EP
Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4420-3. PubMed ID: 6289301
[TBL] [Abstract][Full Text] [Related]
14. L-DOPA preloading increases the uptake of borophenylalanine in C6 glioma rat model: a new strategy to improve BNCT efficacy.
Capuani S; Gili T; Bozzali M; Russo S; Porcari P; Cametti C; D'Amore E; Colasanti M; Venturini G; Maraviglia B; Lazzarino G; Pastore FS
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):562-7. PubMed ID: 18793958
[TBL] [Abstract][Full Text] [Related]
15. Penetration of hematoporphyrin derivative into rat brain and intracerebral 9L glioma tissue.
Boisvert DP; McKean JD; Tulip J; Cummins J; Cheng MK
J Neurooncol; 1985; 3(2):113-8. PubMed ID: 3162004
[TBL] [Abstract][Full Text] [Related]
16. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
Laterra J; Nam M; Rosen E; Rao JS; Lamszus K; Goldberg ID; Johnston P
Lab Invest; 1997 Apr; 76(4):565-77. PubMed ID: 9111517
[TBL] [Abstract][Full Text] [Related]
17. Comparative pharmacokinetics of 14C-sucrose in RG-2 rat gliomas after intravenous and convection-enhanced delivery.
Vavra M; Ali MJ; Kang EW; Navalitloha Y; Ebert A; Allen CV; Groothuis DR
Neuro Oncol; 2004 Apr; 6(2):104-12. PubMed ID: 15134624
[TBL] [Abstract][Full Text] [Related]
18. [MCNU delivery into malignant brain tumor and normal brain tissue by intravenous or intraarterial infusion].
Miyagami M; Tazoe M; Tsubokawa T
Gan To Kagaku Ryoho; 1990 Feb; 17(2):275-80. PubMed ID: 2154161
[TBL] [Abstract][Full Text] [Related]
19. Comparative brain tissue distribution of camptothecin and topotecan in the rat.
El-Gizawy SA; Hedaya MA
Cancer Chemother Pharmacol; 1999; 43(5):364-70. PubMed ID: 10100590
[TBL] [Abstract][Full Text] [Related]
20. In-vivo microdialysis study of the distribution of cisplatin into brain tumour tissue after intracarotid infusion in rats with 9L malignant glioma.
Nakashima M; Shibata S; Tokunaga Y; Fujita H; Anda T; Arizono K; Tomiyama N; Sasaki H; Ichikawa M
J Pharm Pharmacol; 1997 Aug; 49(8):777-80. PubMed ID: 9379355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
